The purpose of this program is to enable community mental health centers to support and restore the delivery of clinical services that were impacted by the COVID-19 pandemic and effectively address the needs of individuals with serious emotional disturbance (SED), serious mental illness (SMI), and individuals with SMI or SED and substance use disorders, referred to as co-occurring disorder (COD). SAMHSA recognizes the needs of individuals with behavioral health conditions, including minority populations and economically disadvantaged communities, have not been met during the pandemic and that CMHC staff and other caregivers have been impacted.
Awards will be between $1m and $5m over two years (depending on population size). SAMHSA anticipates making between 165 and 825 awards.
According to SAMHSA, if the provider is not a CMHC but meets the 1913(c) criteria of the Public Health Services (PHS) Act, and as long as the provider is licensed/certified by the state or any nationally recognized accreditation organization, the provider can apply.
SAMHSA is accepting applications for Medication-Assisted Treatment Prescription Drug and Opioid Addiction (MAT-PDOA) grants. The purpose of this program is to expand/enhance access to medication-assisted treatment (MAT) services for persons with an opioid use disorder seeking or receiving MAT.
SAMHSA plans to issue approximately 89 to 135 awards of up to $1 million per year for states and up to $525,000 per year for other domestic public or non-profit entities for up to 5 years.
SAMHSA is accepting applications for Screening, Brief Intervention, and Referral to Treatment (SBIRT) grants. The purpose of this program is to implement screening, brief intervention, and referral to treatment services for children, adolescents, and/or adults in primary care and community health settings (e.g., health centers, hospital systems, health maintenance organizations (HMOs), preferred-provider organizations (PPOs), Federally Qualified Health Care (FQHC) systems, behavioral health centers, pediatric health care providers, Children’s Hospitals, etc.) with a focus on screening for underage drinking, opioid use, and other substance use. These grants support clinically appropriate services for persons at risk (asymptomatic) for substance use disorder (SUD), as well as those diagnosed with SUD.
SAMHSA plans to issue approximately 10 awards of up to $995,000 per year for up to 5 years.